N-hydroxy-2-acetylaminofluorene inhibition of rat live RNA polymerases.
Administration of N-hydroxy-2-acetylaminofluorene (N-OH-AAF) to rats inhibits liver nuclear RNA synthesis. This effect is reflected in an in vitro inhibition of RNA synthesis by isolated whole nuclei. The decreased RNA synthesis can be accounted for entirely by an inhibition of the RNA polymerase activities quantitatively solubilized and partially purified from these nuclei. Both nucleolar and nucleoplasmic polymerases are affected. A similar inhibition of the polymerases was demonstrated in intact nuclei by inactivating the endogenous template with actinomycin D and assaying the polymerases with an added exogenous template, poly(deoxyadenylate-deoxythymidylate). Chromatin was prepared from similar nuclear preparations by two methods, differing in the extent to which they remove endogenous polymerase activity. Each chromatin preparation was transcribed with added Escherichia coli or partially purified rat liver nucleoplasmic RNA polymerase respectively. With either polymerase and either chromatin preparation, no inhibition of the template activity of chromatin isolated from N-OH-AAF-treated animals could be detected. It is concluded that N-OH-AAF is a potent inhibitor of rat liver nuclear RNA synthesis and that the mechanism of this inhibition is inactivation of the RNA polymerases. At the same time, N-OH-AAF leaves the chromatin template, at least quantitatively, intact for the synthesis of RNA. The implications of such an effect of N-OH-AAF on RNA synthesis are discussed.
D000227:Adenine Nucleotides; D000818:Animals; D002466:Cell Nucleolus / Q000201:enzymology; D002467:Cell Nucleus / Q000201:enzymology; D002843:Chromatin / Q000187:drug effects; D002852:Chromatography, Ion Exchange; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors*; D003609:Dactinomycin / Q000494:pharmacology; D003864:Depression, Chemical; D005449:Fluorenes / Q000494:pharmacology*; D006881:Hydroxyacetylaminofluorene / Q000494:pharmacology*; D008099:Liver / Q000648:ultrastructure; D011119:Polynucleotides / Q000494:pharmacology; D051381:Rats; D012995:Solubility; D013698:Templates, Genetic; D013942:Thymine Nucleotides; D014158:Transcription, Genetic / Q000187:drug effects
D000227:Adenine Nucleotides; D002843:Chromatin; D005449:Fluorenes; D011119:Polynucleotides; D013942:Thymine Nucleotides; D003609:Dactinomycin; D006881:Hydroxyacetylaminofluorene; D012321:DNA-Directed RNA Polymerases